Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Mencevax ACWY in Filipino Subjects
NCT00290329Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2006
- Primary completion
- Oct 2006
- Modality
- Antibody-Drug Conjugates (ADCs), Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal ACYW135 vaccine in meningococcal infection, sponsored by GSK. Started Jan 2006; status: completed.
02
Drugs
meningococcal ACYW135 vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00290329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290329.